Filing Details
Translational Development Acquisition Corp. (NASDAQ:TDAC) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:TDAC
Translational Development Acquisition Corp. (TDAC) Reports Material Event to SEC
Filing Details Translational Development Acquisition Corp. (NASDAQ:TDAC) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material…
Market Context
Translational Development Acquisition Corp.'s stock currently trades at $10.70 with a market capitalization of $229.2M. The Financial Services company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Translational Development Acquisition Corp.'s stock.
All SEC filings for Translational Development Acquisition Corp. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TDAC Stock Page
Frequently Asked Questions
Where can I read TDAC's SEC filings?
Browse all filings on our TDAC SEC filings page.
What types of SEC filings does Translational Development Acquisition Corp. file?
Public companies like Translational Development Acquisition Corp. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.